Pharmagest: growth of more than 12% in turnover in 2021


(CercleFinance.com) – Pharmagest Interactive publishes a turnover for 2021 up 12.4% to 193.1 million euros, including +12.2% to 142.9 million for its Europe pharmacy solutions division with a significant contribution from external growth operations.

The group of IT solutions for health specifies that on a comparable basis (excluding acquisitions of ASCA Informatique, Pharmagest Servizi, Athesia), the annual turnover of its main division increased by 6.1% to 135.1 million.

Pharmagest anticipates ‘excellent results’ for the year 2021 and approaches the 2022 financial year with confidence, highlighting the ‘Ségur de la Santé’ which ‘will make it possible to accelerate the deployment of software solutions in the ecosystem’ of the group.

Copyright © 2022 CercleFinance.com. All rights reserved.

Did you like this article ? Share it with your friends with the buttons below.





Facebook


LinkedIn


E-mail





Source link -85